Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Takeda Pharmaceutical ADR Rep 0.5 Ord Shs TAK

Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research and development, manufacture, sale and licensing of pharmaceuticals. The Company focuses on the main business areas of gastrointestinal diseases, rare diseases, plasma derivatives (immune diseases), oncology (cancer), and neuroscience (neuropsychiatric diseases). The Company focuses on three research and development areas: innovative biopharmaceuticals with the focus on gastrointestinal and inflammatory diseases, neuroscience, and oncology, plus plasma derivatives and vaccines. Most of the pharmaceuticals treat rare diseases in the focus disease areas and the plasma derivatives area. The Company operates in Japan, the United States, Europe, and China.


NYSE:TAK - Post by User

User Avatar Image
(22)
•••
  • GoldBrookeX
Post by GoldBrookeon Jan 25, 2021 9:59am
404 Views
Post# 32374309

colchicine vs covid

colchicine vs covid
We got a new credible study out of Quebec. This drug is preventing: hospitalizations by 25%, the need for mechanical ventilation by 50%, and deaths by 44% This is incredible, every first world government could save money on healthcare costs, not to mention save people by buying this. It may also provide a temporary measure for those hard to get frozen vaccine to areas. I'd like to do some napkin math but currently unsure of the drugs current cost. But I bet governments would spend up to 1k/person and still save money over ventilation and hospitalization. https://www.globenewswire.com/news-release/2021/01/23/2163109/0/en/Colchicine-reduces-the-risk-of-COVID-19-related-complications.html
<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities